Purpose: Colorectal cancer is a common cancer in Indonesia, yet 13 it has been understudied. We conduct a genome-wide association study focused 14 on evaluation and discovery of colorectal cancer risk factors in Indonesians. 15 Methods: We administered detailed questionnaires and collecting blood sam-16 ples from 162 colorectal cancer cases throughout Makassar, Indonesia. We also 17 established a control set of 193 healthy individuals frequency matched by age, 18 sex, and ethnicity. A genome-wide association analysis was performed on 84 19 cases and 89 controls passing quality control. We evaluated known colorectal 20 cancer genetic variants using logistic regression and established a genome-wide 21 polygenic risk model using a Bayesian variable selection technique.
in the SCL22A3, SCG5, GREM1, and STXBP5-AS1 genes and colorectal on the GeneTitan MC instrument (Thermo Fisher Scientific, Wilmington, DE, Table 3 . Variants with evidence of replication (p-value < 0.05) were flagged 149 for further investigation. 150 We also developed a polygenic model considering the joint effect of mul-151 tiple genetic variants on colorectal cancer. We selected the top 200 SNPs, 152 based on Bayes factors [18] , as candidate predictors in this joint model. Bayes 153 factors were computed for the marginal versus the null models for each SNP 154 while controlling for gender, age, BMI, and smoking status. To jointly model 155 these variants, we use a Bayesian variable selection technique. In particular, 156 we fit a logistic regression model utilizing shrinkage priors for each of the Results for previously reported colorectal cancer SNPs are presented in Figure 1 and Supplementary Table 3 . There is evidence of replication for the 190 following genetic variants: rs9497673, rs6936461 and rs7758229 on chromosome 191 6; rs11255841 on chromosome 10; and rs4779584, rs11632715, and rs73376930 192 on chromosome 15. The regions are characterized in Figures 2, 3, 4, and 5. 193 The pattern of associations is rather diffuse in the STXBP5-AS1 (STXBP5 194 Antisense RNA 1) and SLC22A3 genes of chromosome 6, representing the 195 correlation among the variants in these regions (Figures 2 and 3) . Similarly, 196 the association pattern tapers along chromosome 10. The strongest associa-197 tion pattern can be found on chromosome 15. This region has a more defined 198 peak than the other regions with associations spanning two genes: SCG5 (se-199 cretogranin V) and GREM1 (gremlin 1, DAN family BMP antagonist).
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The polygenic analysis identified 10 SNPs which appear to have a relatively 201 strong association (i.e., large effect size) with the risk of developing colorectal 202 cancer. Five of these SNPs lie in intergenic regions; three lie in introns of 203 ARHGEF3, PLCG2, and RGMB ; one is a deletion in PIGN ; and one is an 
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The region on chromosome 15 nearby SCG5 and GREM1 have been flagged 247 in multiple GWAS, e.g., [37] . We replicated colorectal cancer associations for 248 rs4779584 (p=0.018), rs11632715 (p=0.004), and rs73376930 (p=0.010). Inter-249 estingly, the smallest p-value in the region was rs10083612 within an intron of 250 SCG5 (p=1.61e-5, see Figure 5 ). The role of SCG5 in colorectal cancer has not 251 been well characterized, while much is known about its neighbor GREM1 's role 252 in colorectal cancer. GREM1, which is one of the antagonists of the bone mor-253 phogenetic proteins (BMPs) found within the TGF-beta signaling pathway, 254 has been found to be important for the survival and proliferation of several 255 types of cancers [38] . In particular, modulated expression of GREM1 is found 256 in cancer-associated stromal cells. GREM1 is also found to be a proangio-257 genic factor, suggesting a role in cancer development when it is upregulated The duplication is the basis for an autosomal dominant HMPS condition that 265 is prevalent among the Ashkenazi Jewish population and is a recommended 266 biomarker/genetic test to detect CRC in this population. Aberrant expres-267 sion of GREM1 has also been shown to underlie oncogenesis within the large 268 intestines and colon [41] .
269
Two of the previously identified colorectal cancer markers replicate in this 270 study (rs6936461 and rs9497673; see Table 3 ). These SNPs are located in the 271 intronic regions of STXBP5-AS1 on chromosome 6. Using bioinformatics tools, 272 it is predicted that changes from T to A in rs6936461 and A to G in rs9497673, 273 has the potential to alter the splicing of the gene [42] . STXBP5-AS1 is an long Fig. 1 Results for known colorectal cancer susceptibility SNPs. Variants with p-values < 0.05 were flagged for further investigation. 
